脑膜瘤MMP-2、9及TIMP-1 mRNA表达与瘤周水肿的相关性研究  

Correlation between the expressions of matrix metalloproteinases-2、9 and tissue inhibitor of metalloproteinase-1 mRNA in meningioma and peritumoral edema

在线阅读下载全文

作  者:杨金焰[1] 郭毅[2] 谭艳丽[3] 田春辉[2] 方川[2] 史彦芳[2] 王佳良[2] 韩颖[2] 

机构地区:[1]河北省保定市第一医院,071000 [2]河北大学附属医院 [3]河北大学医学部

出  处:《河北医药》2008年第7期939-940,共2页Hebei Medical Journal

基  金:河北省科技攻关计划项目(编号:052761124)

摘  要:目的研究脑膜瘤中基质金属蛋白酶2、9(MMP-2、9)及其抑制因子TIMP-1 mRNA表达与其瘤周水肿(PTE)的相关性。方法36例经MRI检查及手术、病理证实的脑膜瘤,根据PTE程度分为2组:无或轻度水肿组和中重度水肿组,将手术标本以免疫组化染色和原位杂交方法对MMP-2、9和TIMP-1 mRNA表达行半定量检测,分析与脑膜瘤瘤周水肿之间的相关性。结果脑膜瘤的瘤周水肿程度与MMP2(P<0.05)和MMP-9(P<0.05)的表达强度差异有统计学意义。而TIMP-1 mRNA的表达在无或轻度水肿组和中重度水肿组之间差异无统计学意义(P>0.05)。结论MMP-2、9的表达及MMP/TIMP比例失衡在脑膜瘤的高侵袭性和瘤周水肿程度的发生中起关键作用,PTE作为脑膜瘤MRI影像的一个重要特征,因反映了肿瘤的侵袭程度,故可作为临床预后评价的指标之一。Objective To determine whether the expressions of Matrix Metalloproteinases-2,9 ( MMP-2, 9) and Tissue Inhibitor of Metalloproteinase- 1 (TIMP- 1 ) mRNA are correlated with the degree of peritumoral edema (PTE) in human meningioma. Methods 36 meningioma specimens were collected for the retrospective analysis, which were testified by MRI, and proved by operation and pathology. According to the degrees of PIE, the patients were divided into 2 groups: one with minimum to mild edema and the other with moderate to mild edema.The expressions of MMP-2,9 and TIMP lmRNA level were semi-quantified in tissue sections by immunohistochemical techniques and in situ hybridization respectively, the results of staining were compared with the degrees of PIE. Results A statistical significance was found between the expressions of MMP-2 ( P = 0. 012) , MMP-9 ( P = 0. 005 ) and the degree of PIE in meningioma. No statistical significance between the expression of TIMP-1mRNA and degree of PIE. Conclusion MMP-2,9 as well as MMPs/TIMP ratio may play an important role in the invasion of meningioma and its PIE degrees. In addition, as one of the most valuable MRI characteristics of meningioma , PIE may predict the prognosis of meningiomas.

关 键 词:脑膜瘤 磁共振波谱学 瘤周水肿 明胶酶 基质金属蛋白酶组织抑制因子 

分 类 号:R739.45[医药卫生—肿瘤] R575.2[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象